Hot Features
Premium
Register for Free to get streaming real-time quotes, interactive charts, live options flow, and more.
Period:
Draw Mode:
| Volume | 5,022,451 |
|
|||||
| News | - | ||||||
| Day High | 1.22 | Low High |
|||||
| Day Low | 1.09 | ||||||
| Share Name | Share Symbol | Market | Stock Type |
|---|---|---|---|
| X4 Pharmaceuticals Inc | XFOR | NASDAQ | Common Stock |
| Price Change | Price Change % | Share Price | Last Trade
|
|
|---|---|---|---|---|
| 0.05 | 4.59% | 1.14 | 18:54:08 |
| Open Price | Low Price | High Price | Close Price | Previous Close |
|---|---|---|---|---|
| 1.20 | 1.09 | 1.22 | 1.12 | 1.09 |
| Trades | Shares Traded | VWAP | Financial Volume | Average Volume | 52 Week Range |
|---|---|---|---|---|---|
| 10,644 | 5,022,451 | US$ 1.15 | US$ 5,792,007 | - | 0.5723 - 2.575 |
| Last Trade | Type | Quantity | Price | Currency |
|---|---|---|---|---|
| 18:55:16 | 10 | US$ 1.17 | USD |
X4 Pharmaceuticals Inc Financials
| Market Cap | Shares in Issue | Float | Revenue | Profit/Loss | EPS | PE Ratio |
|---|---|---|---|---|---|---|
| 187.37M | 167.29M | - | 0 | -101.17M | -0.60 | - |
| Short Interest | Dividends Per Share | Dividend Yield | Ex-Div Date | Insider B/S | Insider % Owned |
|---|---|---|---|---|---|
| - | - | - | - |
X4 Pharmaceuticals News
|
|
{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}} |
Loading Messages....
Historical XFOR Price Data
| Period † | Open | High | Low | VWAP | Avg. Daily Vol | Change | % |
|---|---|---|---|---|---|---|---|
| 1 Week | 1.36 | 1.39 | 0.90 | 1.14 | 8,426,120 | -0.22 | -16.18% |
| 1 Month | 1.37 | 1.60 | 0.90 | 1.23 | 4,204,399 | -0.23 | -16.79% |
| 3 Months | 0.89 | 1.60 | 0.82 | 1.19 | 3,094,013 | 0.25 | 28.09% |
| 6 Months | 0.73 | 1.60 | 0.5723 | 0.9943657 | 2,646,502 | 0.41 | 56.16% |
| 1 Year | 1.48 | 2.575 | 0.5723 | 1.34 | 2,710,032 | -0.34 | -22.97% |
| 3 Years | 8.42 | 9.90 | 0.5723 | 1.51 | 1,357,466 | -7.28 | -86.46% |
| 5 Years | 19.52 | 22.50 | 0.5723 | 1.80 | 839,839 | -18.38 | -94.16% |
X4 Pharmaceuticals Description
| X4 Pharmaceuticals Inc is clinical-stage biopharmaceutical company. It is focused on restoring the immune system function by developing therapeutics for the treatment of rare diseases. Its molecule therapeutics are antagonists of chemokine receptor CXCR4, which have the potential to treat a broad range of rare diseases, including primary immunodeficiencies (PIs) and cancer. Its product candidate, X4P-001, has completed a Phase 2 trial in patients with a rare genetic PI called Warts. The company is also developing X4P-002, a CXCR4 antagonist that has properties that could enable penetration of the blood-brain barrier and provide appropriate therapeutic exposures to treat brain cancers, including glioblastoma multiforme. |
